AZD1222

Category

New England’s ActivMed Practices & Research Conducts Phase 3 COVID-19 Vaccine Trial in Portsmouth, New Hampshire

Residents in Massachusetts and New Hampshire can now participate in the pivotal Phase 3 trial testing the COVID-19 vaccine developed at Oxford University and now sponsored by AstraZeneca, known as AZD1222. Conducted by ActivMed Practices & Research LLC, the trial...

Volunteer in the AstraZeneca AZD1222 Clinical Trial Dies in Brazil, However, Reports are Death Not Connected to Oxford Vaccine: Trial Apparently to Proceed

Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s food and drug regulator Anvisa. According to Reuters’ reports, the national coordinator of the study, the Federal University of Sao...

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review

The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting with AstraZeneca’s AZD1222 or the “Oxford” vaccine. This committee is investigating the first batch of data on the vaccine...

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

Monday, AstraZeneca said it has begun Phase 3 trials of AZD1222, its COVID-19 vaccine candidate. This makes them the third firm to be in Phase 3 for the virus. As chronicled by CNN August 31 and updated September 1, the vaccine is developed with Oxford University and...

Pin It on Pinterest